New analysis conducted by Newmarket Strategy to mark Rare Disease Day illustrates the ongoing challenge of bringing forward new treatments for people living with a rare disease. Our analysis of…
“Life Sciences will be one of the great drivers of growth in the twenty first century.” The first sentence of the foreword to the British Government’s new Life Sciences Vision…
The entrance of biosimilar competitors into a therapeutic area is an ever-present concern for pharmaceutical companies managing ageing product portfolios. On the other hand, any potential benefit to patients and…